BioLineRx Ltd.
BLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498403
No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in BioLineRx Ltd. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- 0 vs. Q4 2023
- Shares held
- 1.30M
- +249.7K (+23.7%) vs. Q4 2023
- Total value
- $1.47M
- −$179.6K (−10.9%) vs. Q4 2023
- New holders
- 5
- 9 more added
- Sold out
- 5
- 6 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $206.7K |
| Q1 2026 | 13 | $45.2K |
| Q4 2025 | 14 | $135.6K |
| Q3 2025 | 14 | $104.3K |
| Q2 2025 | 17 | $302.1K |
| Q1 2025 | 12 | $28.0K |
| Q4 2024 | 32 | $435.9K |
| Q3 2024 | 32 | $1.34M |
| Q2 2024 | 31 | $2.42M |
| Q1 2024 | 28 | $1.47M |
| Q4 2023 | 29 | $1.75M |
| Q3 2023 | 29 | $2.46M |
| Q2 2023 | 26 | $1.97M |
| Q1 2023 | 20 | $2.91M |
| Q4 2022 | 18 | $3.37M |
| Q3 2022 | 28 | $10.3M |
| Q2 2022 | 28 | $1.36M |
| Q1 2022 | 26 | $1.99M |
| Q4 2021 | 30 | $5.09M |
| Q3 2021 | 30 | $6.69M |
| Q2 2021 | 30 | $4.01M |
| Q1 2021 | 29 | $13.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding BioLineRx Ltd.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 291,354 | $326.3K | 0.00% | +53,093+22.3% | Added |
| Susquehanna International Group, LLP | 204,914 | $229.5K | 0.00% | +74,920+57.6% | Added |
| Values First Advisors, Inc. | 203,633 | $228.1K | 0.13% | +151,465+290.3% | Added |
| LPL Financial LLC | 100,323 | $112.4K | 0.00% | 00.0% | Unchanged |
| Atria Wealth Solutions, Inc. | 99,333 | $111.3K | 0.00% | −11,033−10.0% | Reduced |
| Envestnet Asset Management Inc | 54,405 | $60.9K | 0.00% | +7,758+16.6% | Added |
| Geode Capital Management, LLC | 39,993 | $44.8K | 0.00% | 00.0% | Unchanged |
| Rathbone Brothers plc | 39,820 | $44.6K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 38,500 | $43.1K | 0.00% | −2,000−4.9% | Reduced |
| National Asset Management, Inc. | 21,300 | $38.8K | 0.00% | +2,010+10.4% | Added |
| Wells Fargo & Company | 32,035 | $35.9K | 0.00% | +23,500+275.3% | Added |
| XTX Topco Ltd | 31,492 | $35.3K | 0.00% | +31,492 | New |
| Rhumbline Advisers | 18,332 | $20.5K | 0.00% | −466−2.5% | Reduced |
| Cetera Investment Advisers | 18,030 | $20.2K | 0.00% | +7,146+65.7% | Added |
| Two Sigma Securities, LLC | 17,264 | $19.3K | 0.00% | +17,264 | New |
| Cutter & CO Brokerage, Inc. | 16,667 | $18.7K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 13,835 | $15.5K | 0.00% | −26,600−65.8% | Reduced |
| Creative Planning | 12,982 | $14.5K | 0.00% | −1,600−11.0% | Reduced |
| UBS Group AG | 12,569 | $14.1K | 0.00% | +12,269+4,089.7% | Added |
| Nemes Rush Group LLC | 12,000 | $13.4K | 0.00% | 00.0% | Unchanged |
| Gradient Investments LLC | 9,000 | $10.1K | 0.00% | +7,100+373.7% | Added |
| GWM Advisors LLC | 4,300 | $4.82K | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 3,990 | $4.47K | 0.00% | +3,990 | New |
| Group One Trading, L.P. | 3,188 | $3.57K | 0.00% | +3,188 | New |
| Simplex Trading, LLC | 1,984 | $2.00K | 0.00% | +1,984 | New |
| Advisor Group Holdings, Inc. | 1,206 | $1.35K | 0.00% | −13,119−91.6% | Reduced |
| Tradewinds Capital Management, LLC | 200 | $224 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 66 | $0 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −30,351−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,215−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −22,972−100.0% | Sold out |
| Allen Mooney & Barnes Investment Advisors LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −117−100.0% | Sold out |
| PVG Asset Management Corp | – | – | – | – | Not filed |